Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28.
Papp, K A, K Reich, A Blauvelt, A B Kimball, M Gooderham, S K Tyring, R Sinclair, et al. 2019. “Efficacy of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomized Controlled Trials at Weeks 12 and 28.”. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (6): 1098-1106.